Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiformeSzu‐Ting Chou, Julia Y. Ljubimova|Journal of Controlled Release|2016Cited by 51